PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

UC Davis clinical trial shows biomarkers hold clue in treating aggressive prostate cancer

Clinical trial tests new treatment approach, offers hope for personalized therapies

2025-05-30
(Press-News.org) Many men with aggressive prostate cancer can experience a high rate of recurrence despite treatment.

A new Phase 2 clinical trial at UC Davis Comprehensive Cancer Center unveiled clues as to why these patients are doing poorly and may offer hope in the form of targeted therapy.

The findings will be presented at the annual American Society of Clinical Oncology (ASCO) conference on June 3 in Chicago. .

Pilot trial sheds new clues                                                                                                                                       

UC Davis Comprehensive Cancer Center is testing a drug called niraparib (ZEJULA), given before prostate cancer surgery. Researchers think it could enable more personalized treatments— especially for men with prostate cancer that has specific DNA repair gene mutations.

The pilot trial (NCT04030559) looked at whether giving the PARP inhibitor niraparib before surgery could help prevent cancer from returning in men with aggressive prostate cancer.

A total of 11 men with high-risk prostate cancer and certain biomarkers, specifically gene mutations, took part in the study. Each patient received 200 mg of niraparib daily for 90 days before undergoing surgery.

The study group had a median age of 68 years and a median prostate-specific antigen (PSA) at diagnosis of 10.7 ng/mL. Genetic alterations included germline mutations in BRCA2, MSH6, and CHEK2, and somatic mutations in ATM, SPOP, KMT2C, KMT2D, among others. Germline mutations in DNA are inherited while somatic mutations happen after conception.

Outcome shows the complexity of prostate cancer

While the drug didn’t dramatically shrink tumors before surgery, the study showed the potential of using genetic testing and blood-based monitoring to better understand and track prostate cancer. Notably, circulating tumor DNA (ctDNA) biomarker analysis proved useful in tracking tumor evolution and resistance mechanisms in real time. ctDNA is small fragments of DNA that cancer cells release into the bloodstream.

“This study shows how complex prostate cancer can be, especially in men with certain gene mutations,” said Marc Dall’Era, chief of UC Davis Health’s Department of Urologic Surgery and lead researcher. “Although responses were variable, especially in patients with BRCA2 mutations, this study points to ctDNA as a promising tool to identify who might benefit from targeted neoadjuvant therapies.”

The research team is now continuing to analyze the data to better understand why some cancers resist treatment and how to design future therapies that are more tailored to each individual.

Other researchers included Primo Lara Jr., Nicholas Mitsiades, Mamta Parikh, John McPherson and Kenneth Iczkowski, Irene Mitsiades and Aedric Lim.

Jannsen Pharmaceuticals funded the clinical trial.

 

END


ELSE PRESS RELEASES FROM THIS DATE:

UT Health San Antonio researchers discover new links between heart disease and dementia

2025-05-30
SAN ANTONIO, May 30, 2025 – People who are at higher risk for heart disease also seem more likely to develop dementia. And research led by The University of Texas Health Science Center at San Antonio (UT Health San Antonio) has discovered new associations between various lipid, or fat, levels in the blood and the risk of developing Alzheimer’s disease, the most common cause of dementia worldwide. The findings mean that using blood lipid profiles could help better understand, predict and possibly even prevent the disease in the future. In more than 800 older adults who were part of the long-running Framingham Heart Study, the researchers ...

AADOCR announces new SCADA/Dentsply Sirona Research Award

2025-05-30
Alexandria, VA – AADOCR and the Student Competition for Advancing Dental Research and its Application (SCADA) Alumni Association are pleased to announce the AADOCR SCADA/Dentsply Sirona Research Award. The new award was created to support dentist-scientists, including SCADA program alumni, in their research careers. The award’s immediate goal is to support early-stage dentist-scientists such as post-doctoral scholars and pre-tenure faculty members, with a long-term objective of increasing the number of successfully funded dentist-scientists ...

Mass General Brigham researchers present key findings at ASCO

2025-05-30
Researchers from Mass General Brigham will present research discoveries and outcomes from clinical trials in cancer at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting, held May 30-June 3, in Chicago. ASCO brings together leading experts in clinical oncology to share the latest breakthroughs in cancer research, science and medicine. Presentations from Mass General Brigham investigators include an update on the INCIPIENT trial (using CAR-T in patients with glioblastoma), advances in skin cancer and gynecologic cancer treatment, a new way to radiate multiple brain metastases at the same time, and an app created to help caregivers ...

Student researchers put UTA on national stage

2025-05-30
University of Texas at Arlington biochemistry major Debby Sunday showcased her research at a recent American Chemistry Society conference at East Texas A&M in Commerce. Her findings on photosynthesizers and bacteria earned second place in the undergraduate competition. “This was the first research conference I ever attended, and my experience was very educational,” said Sunday, a graduate of Lake Ridge High School in Mansfield. “Other chemists from across the metroplex presented their various research, from inorganic chemistry to physical chemistry to biochemistry. Not ...

Hertz Foundation and Breakthrough Energy partner to advance climate and energy solutions

2025-05-30
The Hertz Foundation, a nonprofit dedicated to empowering the nation’s most promising innovators in science and technology, and Breakthrough Energy Discovery, a Breakthrough Energy platform focused on pre-venture, early-stage clean technology, have announced a new partnership to advance transformative climate and energy solutions. This collaboration brings together two organizations with a shared commitment to advancing scientific innovation and supporting exceptional talent. By connecting Breakthrough Energy’s innovation platform with the Hertz Foundation’s renowned community of scientific leaders, the partnership will create new opportunities ...

New study reveals how tiny insects detect force

2025-05-30
HUNTINGTON, W.Va. — A newly published study in the Journal of Neurophysiology reveals how blow flies (Calliphora vicina)—despite their minimal body weight—reliably detect forces through specialized sensory organs in their legs. The research offers new insights into insect biomechanics and presents promising applications for the design of next-generation walking robots.  Researchers at Marshall University and West Virginia University examined the behavior of campaniform sensilla—strain-detecting ...

New 3D genome mapping technology sheds light on how plants regulate photosynthesis

2025-05-30
Chinese researchers have developed a groundbreaking technology that sheds light on how the three-dimensional (3D) organization of plant genomes influences gene expression—especially in photosynthesis. The research, which was led by Prof. XIAO Jun at the Institute of Genetics and Developmental Biology of the Chinese Academy of Sciences, in collaboration with BGI Research, was published in Science Advances on May 30.   The innovative method not only provides a more precise tool for understanding the intricate 3D interactions between genes, but also highlights the critical role of long-range chromatin interactions ...

Dinosaur eggshell study confirms biogenic origin of secondary eggshell units

2025-05-30
The calcitic layers of the eggshells of archosaurs (including crocodilians and birds) and turtles are composed of distinctive crystalline structures known as eggshell units. Those growing from the shell membrane are called primary eggshell units (PEUs), while those forming within the calcitic layer are called secondary eggshell units (SEUs). Although rare in modern bird eggs, SEUs are common in dinosaur eggs. Due to the lack of in-depth research on this structure, however, scientists are uncertain whether they are biogenic or abiogenic in origin. To tackle this issue, an international ...

Transforming immunotherapy design

2025-05-30
The University of Pittsburgh’s Natasa Miskov-Zivanov, assistant professor of electrical and computer engineering, has received a prestigious Faculty Early Career Development (CAREER) Award of $581,503 from the National Science Foundation (NSF) for her project titled “Artificial Intelligence-Driven Framework for Efficient and Explainable Immunotherapy Design.” Through her novel approach and the development of an automated system that leverages AI and knowledge graphs to design more effective lymphocytes, she hopes to transform the ...

New book with a global view of men’s experiences with partner violence

2025-05-30
More than two decades ago, Denise Hines began investigating a topic most researchers wouldn’t touch: men as victims of intimate partner violence (IPV). She and collaborator Emily Douglas were the first in the U.S. to earn federal funding for this line of research, publishing studies that challenged entrenched gender assumptions and provoked debate in the field.  Their new book, The Routledge Handbook of Men’s Victimization in Intimate Relationships, offers the most thorough international synthesis ...

LAST 30 PRESS RELEASES:

Antibiotics can affect the gut microbiome for several years 

Study: Electrical stimulation can restore ability to move limbs, receive sensory feedback after spinal cord injury

Rice scientists unveil new tool to watch quantum behavior in action

Gene-based therapies poised for major upgrade thanks to Oregon State University research

Extreme heat has extreme effects r—but some like it hot

Blood marker for Alzheimer’s may also be useful in heart and kidney diseases

Climate extremes hinder early development in young birds

Climate policies: The swing voters that determine their fate

Building protection against infectious diseases with nanostructured vaccines

Oval orbit casts new light on black hole - neutron star mergers

Does online sports gambling affect substance use behaviors?

How do rapid socio-environmental transitions reshape cancer risk?

Do abortion bans affect birth rates and food-assistance costs?

Can artificial intelligence help reduce the carbon footprint of weather forecasting models?

Mangrove forests are short of breath

Low testosterone, high fructose: A recipe for liver disaster

SKKU research team unravels the origin of stochasticity, a key to next-generation data security and computing

Flexible polymer‑based electronics for human health monitoring: A safety‑level‑oriented review of materials and applications

Could ultrasound help save hedgehogs?

attexis RCT shows clinically relevant reduction in adult ADHD symptoms and is published in Psychological Medicine

Cellular changes linked to depression related fatigue

First degree female relatives’ suicidal intentions may influence women’s suicide risk

Specific gut bacteria species (R inulinivorans) linked to muscle strength

Wegovy may have highest ‘eye stroke’ and sight loss risk of semaglutide GLP-1 agonists

New African species confirms evolutionary origin of magic mushrooms

Mining the dark transcriptome: University of Toronto Engineering researchers create the first potential drug molecules from long noncoding RNA

IU researchers identify clotting protein as potential target in pancreatic cancer

Human moral agency irreplaceable in the era of artificial intelligence

Racial, political cues on social media shape TV audiences’ choices

New model offers ‘clear path’ to keeping clean water flowing in rural Africa

[Press-News.org] UC Davis clinical trial shows biomarkers hold clue in treating aggressive prostate cancer
Clinical trial tests new treatment approach, offers hope for personalized therapies